Thorac Cardiovasc Surg 2023; 71(04): 307-316
DOI: 10.1055/s-0041-1740557
Review Article

Bibliometric Analysis of 50 Most Cited Articles Comparing Lobectomy with Sublobar Resection

Ahmet Kayahan Tekneci
1   Department of Thoracic Surgery, Ege University School of Medicine, İzmir, Turkey
,
Gizem Kececi Ozgur
1   Department of Thoracic Surgery, Ege University School of Medicine, İzmir, Turkey
,
Tevfik Ilker Akcam
1   Department of Thoracic Surgery, Ege University School of Medicine, İzmir, Turkey
,
Ufuk Cagirici
1   Department of Thoracic Surgery, Ege University School of Medicine, İzmir, Turkey
› Author Affiliations

Abstract

Background Recent years have seen an increase in the number of studies of the sublobar resection approach in non–small cell lung cancer (NSCLC) surgery. The purpose of this bibliometric analysis is to assess the significance and impact of articles comparing sublobar resection and lobectomy in NSCLC surgery.

Material and Methods The Web of Science database was searched to identify studies comparing sublobar resection and lobectomy in NSCLC surgery published between 2005 and 2020 (accessed: September 11, 2020). The 50 most cited articles were analyzed by years, countries, authors, authors' affiliations, journals, journals' addresses, and impact factors.

Results The bibliometric analysis revealed that the most cited article had 443 citations, while the total number of citations of all articles was 2,820. The mean number of citations, in turn, was 56.4 ± 75.62 (1–443) times. The highest number of publications over the past 15 years was in 2016, with eight articles. The Annals of Thoracic Surgery (n = 10; 20%) had the highest number of publications on the list. The articles included in the present study were mostly (n = 35, 70%) published in U.S. journals. While multiple subject matters and analyses were presented by many studies, survival was the topic of greatest interest, with 37 (74%) studies.

Conclusion This study revealed that interest in studies comparing sublobar resection with lobectomy has increased in recent years. It also presents both quantitative and qualitative analyses of the most cited articles in the literature on this topic. Therefore, it can serve as a guide for researchers.

Disclosures

All authors declare that this study included no human or animal subjects, and did not benefit from financial support from any organization, and no other relationships or activities exist that may appear to have affected the submitted study.




Publication History

Received: 13 July 2021

Accepted: 21 October 2021

Article published online:
08 February 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
  • 2 Gürbüz M, Ürün Y. Adjuvant treatment in non-small cell lung cancer. J Ankara Univ Fac Med 2018; 71: 112-117
  • 3 Yılmaz Ü. Akciğer kanserlerinde tedavi yaklaşımları. Nucl Med Semin 2018; 4: 32-38
  • 4 Johnson DH, Schiller JH, Bunn Jr PA. Recent clinical advances in lung cancer management. J Clin Oncol 2014; 32 (10) 973-982
  • 5 Wei S, Guo C, He J. et al. Effect of vein-first vs artery-first surgical technique on circulating tumor cells and survival in patients with non-small cell lung cancer: a randomized clinical trial and registry-based propensity score matching analysis. JAMA Surg 2019; 154 (07) e190972
  • 6 Cao C, Chandrakumar D, Gupta S, Yan TD, Tian DH. Could less be more?-A systematic review and meta-analysis of sublobar resections versus lobectomy for non-small cell lung cancer according to patient selection. Lung Cancer 2015; 89 (02) 121-132
  • 7 Schubert A, Glänzel W, Braun T. Scientometric datafiles. A comprehensive set of indicators on 2649 journals and 96 countries in all major science fields and subfields 1981–1985. Scientometrics 1989; 16: 3-478 . Accessed on January 11, 2022 at: https://doi.org/10.1007/BF02093234
  • 8 de Moya-Anegón F, Chinchilla-Rodríguez Z, Vargas-Quesada B. et al. Coverage analysis of Scopus: a journal metric approach. Scientometrics 2007; 73: 53-78
  • 9 Hui J, Han Z, Geng G, Yan W, Shao P. The 100 top-cited articles in orthodontics from 1975 to 2011. Angle Orthod 2013; 83 (03) 491-499
  • 10 Gondivkar SM, Sarode SC, Gadbail AR, Gondivkar RS, Chole R, Sarode GS. Bibliometric analysis of 100 most cited articles on oral submucous fibrosis. J Oral Pathol Med 2018; 47 (08) 781-787
  • 11 Ginsberg RJ, Rubinstein LV. Lung Cancer Study Group. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Ann Thorac Surg 1995; 60 (03) 615-622 , discussion 622–623
  • 12 National Comprehensive Cancer Centers. NCCN clinical practice guidelines in oncology: non-small cell lung cancer v5. 2017 . Accessed July 16, 2018 at: http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf
  • 13 Koike T, Yamato Y, Yoshiya K, Shimoyama T, Suzuki R. Intentional limited pulmonary resection for peripheral T1 N0 M0 small-sized lung cancer. J Thorac Cardiovasc Surg 2003; 125 (04) 924-928
  • 14 Wolf AS, Richards WG, Jaklitsch MT. et al. Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Ann Thorac Surg 2011; 92 (05) 1819-1823 , discussion 1824–1825
  • 15 Veluswamy RR, Ezer N, Mhango G. et al. Limited resection versus lobectomy for older patients with early-stage lung cancer: impact of histology. J Clin Oncol 2015; 33 (30) 3447-3453
  • 16 Varlotto JM, Medford-Davis LN, Recht A. et al. Identification of stage I non-small cell lung cancer patients at high risk for local recurrence following sublobar resection. Chest 2013; 143 (05) 1365-1377
  • 17 Dai C, Shen J, Ren Y. et al. Choice of surgical procedure for patients with non-small-cell lung cancer ≤ 1 cm or > 1 to 2 cm among lobectomy, segmentectomy, and wedge resection: a population-based study. J Clin Oncol 2016; 34 (26) 3175-3182
  • 18 Kates M, Swanson S, Wisnivesky JP. Survival following lobectomy and limited resection for the treatment of stage I non-small cell lung cancer<=1 cm in size: a review of SEER data. Chest 2011; 139 (03) 491-496
  • 19 Mao N, Wang M, Ho Y. A bibliometric study of the trend in articles related to risk assessment published in Science Citation Index. Hum Ecol Risk Assess 2010; 16: 801-824
  • 20 Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact?. Scientometrics 2015; 105 (03) 1809-1831
  • 21 Okada M, Koike T, Higashiyama M, Yamato Y, Kodama K, Tsubota N. Radical sublobar resection for small-sized non-small cell lung cancer: a multicenter study. J Thorac Cardiovasc Surg 2006; 132 (04) 769-775
  • 22 El-Sherif A, Gooding WE, Santos R. et al. Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg 2006; 82 (02) 408-415 , discussion 415–416
  • 23 Schuchert MJ, Pettiford BL, Keeley S. et al. Anatomic segmentectomy in the treatment of stage I non-small cell lung cancer. Ann Thorac Surg 2007; 84 (03) 926-932 , discussion 932–933
  • 24 Altorki NK, Yip R, Hanaoka T. et al; I-ELCAP Investigators. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules. J Thorac Cardiovasc Surg 2014; 147 (02) 754-762 , Discussion 762–764
  • 25 Martin-Ucar AE, Nakas A, Pilling JE, West KJ, Waller DA. A case-matched study of anatomical segmentectomy versus lobectomy for stage I lung cancer in high-risk patients. Eur J Cardiothorac Surg 2005; 27 (04) 675-679
  • 26 Landreneau RJ, Normolle DP, Christie NA. et al. Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis. J Clin Oncol 2014; 32 (23) 2449-2455
  • 27 Tsutani Y, Miyata Y, Nakayama H. et al. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study. J Thorac Cardiovasc Surg 2013; 146 (02) 358-364
  • 28 Kilic A, Schuchert MJ, Pettiford BL. et al. Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly. Ann Thorac Surg 2009; 87 (06) 1662-1666 , discussion 1667–1668
  • 29 Fernando HC, Santos RS, Benfield JR. et al. Lobar and sublobar resection with and without brachytherapy for small stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2005; 129 (02) 261-267
  • 30 Okami J, Ito Y, Higashiyama M. et al. Sublobar resection provides an equivalent survival after lobectomy in elderly patients with early lung cancer. Ann Thorac Surg 2010; 90 (05) 1651-1656
  • 31 Schuchert MJ, Abbas G, Awais O. et al. Anatomic segmentectomy for the solitary pulmonary nodule and early-stage lung cancer. Ann Thorac Surg 2012; 93 (06) 1780-1785 , discussion 1786–1787
  • 32 Kodama K, Higashiyama M, Okami J. et al. Oncologic outcomes of segmentectomy versus lobectomy for clinical T1a N0 M0 non-small cell lung cancer. Ann Thorac Surg 2016; 101 (02) 504-511
  • 33 Speicher PJ, Gu L, Gulack BC. et al. Sublobar resection for clinical stage IA non-small-cell lung cancer in the United States. Clin Lung Cancer 2016; 17 (01) 47-55
  • 34 Yendamuri S, Sharma R, Demmy M. et al. Temporal trends in outcomes following sublobar and lobar resections for small (≤ 2 cm) non-small cell lung cancers–a Surveillance Epidemiology End Results database analysis. J Surg Res 2013; 183 (01) 27-32
  • 35 Eguchi T, Kameda K, Lu S. et al. Lobectomy is associated with better outcomes than sublobar resection in spread through air spaces (STAS)-positive T1 lung adenocarcinoma: a propensity score-matched analysis. J Thorac Oncol 2019; 14 (01) 87-98
  • 36 Altorki NK, Wang X, Wigle D. et al. Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). Lancet Respir Med 2018; 6 (12) 915-924
  • 37 Okumura M, Goto M, Ideguchi K. et al. Factors associated with outcome of segmentectomy for non-small cell lung cancer: long-term follow-up study at a single institution in Japan. Lung Cancer 2007; 58 (02) 231-237
  • 38 Suzuki K, Saji H, Aokage K. et al; West Japan Oncology Group, Japan Clinical Oncology Group. Comparison of pulmonary segmentectomy and lobectomy: safety results of a randomized trial. J Thorac Cardiovasc Surg 2019; 158 (03) 895-907
  • 39 Fiorelli A, Caronia FP, Daddi N. et al. Sublobar resection versus lobectomy for stage I non-small cell lung cancer: an appropriate choice in elderly patients?. Surg Today 2016; 46 (12) 1370-1382
  • 40 Yano M, Yoshida J, Koike T. et al; Japanese Association for Chest Surgery. Survival of 1737 lobectomy-tolerable patients who underwent limited resection for cStage IA non-small-cell lung cancer. Eur J Cardiothorac Surg 2015; 47 (01) 135-142
  • 41 Okada M, Mimae T, Tsutani Y. et al. Segmentectomy versus lobectomy for clinical stage IA lung adenocarcinoma. Ann Cardiothorac Surg 2014; 3 (02) 153-159
  • 42 Yamashita S, Chujo M, Kawano Y. et al. Clinical impact of segmentectomy compared with lobectomy under complete video-assisted thoracic surgery in the treatment of stage I non-small cell lung cancer. J Surg Res 2011; 166 (01) 46-51
  • 43 Nishio W, Yoshimura M, Maniwa Y. et al. Re-assessment of intentional extended segmentectomy for clinical T1aN0 non-small cell lung cancer. Ann Thorac Surg 2016; 102 (05) 1702-1710
  • 44 Zuin A, Andriolo LG, Marulli G. et al. Is lobectomy really more effective than sublobar resection in the surgical treatment of second primary lung cancer?. Eur J Cardiothorac Surg 2013; 44 (02) e120-e125 , discussion e125
  • 45 Dembitzer FR, Flores RM, Parides MK, Beasley MB. Impact of histologic subtyping on outcome in lobar vs sublobar resections for lung cancer: a pilot study. Chest 2014; 146 (01) 175-181
  • 46 Dell'Amore A, Monteverde M, Martucci N. et al. Lobar and sub-lobar lung resection in octogenarians with early stage non-small cell lung cancer: factors affecting surgical outcomes and long-term results. Gen Thorac Cardiovasc Surg 2015; 63 (04) 222-230
  • 47 Zhao X, Qian L, Luo Q, Huang J. Segmentectomy as a safe and equally effective surgical option under complete video-assisted thoracic surgery for patients of stage I non-small cell lung cancer. J Cardiothorac Surg 2013; 8: 116
  • 48 Yang F, Sui X, Chen X. et al. Sublobar resection versus lobectomy in surgical treatment of elderly patients with early-stage non-small cell lung cancer (STEPS): study protocol for a randomized controlled trial. Trials 2016; 17: 191
  • 49 McMurry TL, Shah PM, Samson P, Robinson CG, Kozower BD. Treatment of stage I non-small cell lung cancer: What's trending?. J Thorac Cardiovasc Surg 2017; 154 (03) 1080-1087
  • 50 Bains S, Eguchi T, Warth A. et al. Procedure-specific risk prediction for recurrence in patients undergoing lobectomy or sublobar resection for small (≤2 cm) lung adenocarcinoma: an international cohort analysis. J Thorac Oncol 2019; 14 (01) 72-86
  • 51 Qiu C, Wang G, Xu J. et al. Sublobectomy versus lobectomy for stage I non-small cell lung cancer in the elderly. Int J Surg 2017; 37: 1-7
  • 52 McGuire AL, Hopman WM, Petsikas D, Reid K. Outcomes: wedge resection versus lobectomy for non-small cell lung cancer at the Cancer Centre of Southeastern Ontario 1998-2009. Can J Surg 2013; 56 (06) E165-E170
  • 53 Koike T, Koike T, Sato S. et al; Niigata Chest Surgery Research Group. Lobectomy and limited resection in small-sized peripheral non-small cell lung cancer. J Thorac Dis 2016; 8 (11) 3265-3274
  • 54 Song CY, Sakai T, Kimura D, Tsushima T, Fukuda I. Comparison of perioperative and oncological outcomes between video-assisted segmentectomy and lobectomy for patients with clinical stage IA non-small cell lung cancer: a propensity score matching study. J Thorac Dis 2018; 10 (08) 4891-4901
  • 55 Tsutani Y, Tsubokawa N, Ito M. et al. Postoperative complications and prognosis after lobar resection versus sublobar resection in elderly patients with clinical stage I non-small-cell lung cancer. Eur J Cardiothorac Surg 2018; 53 (02) 366-371
  • 56 Tsutani Y, Mimura T, Kai Y. et al. Outcomes after lobar versus sublobar resection for clinical stage I non-small cell lung cancer in patients with interstitial lung disease. J Thorac Cardiovasc Surg 2017; 154 (03) 1089-1096.e1
  • 57 Ren M, Meng Q, Zhou W. et al. Comparison of short-term effect of thoracoscopic segmentectomy and thoracoscopic lobectomy for the solitary pulmonary nodule and early-stage lung cancer. OncoTargets Ther 2014; 7: 1343-1347
  • 58 Jeon HW, Kim YD, Kim KS, Sung SW, Park HJ, Park JK. Sublobar resection versus lobectomy in solid-type, clinical stage IA, non-small cell lung cancer. World J Surg Oncol 2014; 12: 215
  • 59 Echavarria MF, Cheng AM, Velez-Cubian FO. et al. Comparison of pulmonary function tests and perioperative outcomes after robotic-assisted pulmonary lobectomy vs segmentectomy. Am J Surg 2016; 212 (06) 1175-1182
  • 60 Chiang XH, Hsu HH, Hsieh MS. et al. Propensity-matched analysis comparing survival after sublobar resection and lobectomy for cT1N0 adenocarcinoma. Ann Surg Oncol 2020; 27 (03) 703-715
  • 61 Kamel MK, Rahouma M, Lee B. et al. Segmentectomy is equivalent to lobectomy in hypermetabolic clinical stage IA lung adenocarcinomas. Ann Thorac Surg 2019; 107 (01) 217-223
  • 62 Roman M, Labbouz S, Valtzoglou V. et al. Lobectomy vs. segmentectomy. A propensity score matched comparison of outcomes. Eur J Surg Oncol 2019; 45 (05) 845-850
  • 63 Gu C, Huang Z, Dai C. et al. Prognostic analysis of limited resection versus lobectomy in stage IA small cell lung cancer patients based on the Surveillance, Epidemiology, and End Results Registry Database. Front Genet 2018; 9: 568
  • 64 Kim D, Ferraris VA, Davenport D, Saha S. Outcomes of lobar and sublobar resections for non-small-cell lung cancer: a single-center experience. South Med J 2015; 108 (04) 230-234
  • 65 Cattoni M, Vallières E, Brown LM. et al. Sublobar resection in the treatment of peripheral typical carcinoid tumors of the lung. Ann Thorac Surg 2019; 108 (03) 859-865
  • 66 Lutfi W, Schuchert MJ, Dhupar R. et al. Sublobar resection is associated with decreased survival for patients with early stage large-cell neuroendocrine carcinoma of the lung. Interact Cardiovasc Thorac Surg 2019; 29 (04) 517-524